APA (7th ed.) Citation

NM, A., MM, A., RZ, A., SA, A., IH, H., RA, M., & AM, M. (2015). Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway. Drug design, development and therapy, 9, 3217. https://doi.org/10.2147/DDDT.S86431

Chicago Style (17th ed.) Citation

NM, Al-Rasheed, Al-Oteibi MM, Al-Manee RZ, Al-Shareef SA, Hasan IH, Mohamad RA, and Mahmoud AM. "Simvastatin Prevents Isoproterenol-induced Cardiac Hypertrophy Through Modulation of the JAK/STAT Pathway." Drug Design, Development and Therapy 9 (2015): 3217. https://doi.org/10.2147/DDDT.S86431.

MLA (9th ed.) Citation

NM, Al-Rasheed, et al. "Simvastatin Prevents Isoproterenol-induced Cardiac Hypertrophy Through Modulation of the JAK/STAT Pathway." Drug Design, Development and Therapy, vol. 9, 2015, p. 3217, https://doi.org/10.2147/DDDT.S86431.